Current Recommendations and Novel Strategies for the Management of Skin Toxicities Related to Anti-EGFR Therapies in Patients with Metastatic Colorectal Cancer Maria Carmela AnnunziataAlfonso De StefanoIvana Romano Review Article 01 July 2019 Pages: 825 - 834
Bayesian Network Meta-Analysis for Assessing Adverse Effects of Anti-hepatitis B Drugs Yi ShenYulong JiaPengcheng Xun Systematic Review 21 June 2019 Pages: 835 - 846
Proton Pump Inhibitor Therapy and Hepatic Encephalopathy Risk in Cirrhotic Patients: A Systematic Review with Meta-analysis Dawei ShiZiye ZhouQinqin Cao Systematic Review 10 June 2019 Pages: 847 - 856
Drug–Drug Interactions in Children and Adolescents Receiving Ledipasvir/Sofosbuvir for the Treatment of Hepatitis C Virus Infection Hala Mohsen AbdullatifRania RamziHanaa Mostafa El-Karaksy Original Research Article 25 June 2019 Pages: 857 - 864
Efficacy of Platelet-rich Plasma for Treating Androgenic Alopecia of Varying Grades Qian QuPanli ShiZhiqi Hu Original Research Article 21 June 2019 Pages: 865 - 872
Safety, Tolerability, and Pharmacokinetics of GDC-0276, a Novel NaV1.7 Inhibitor, in a First-in-Human, Single- and Multiple-Dose Study in Healthy Volunteers Michael E. RothenbergMichael TagenWilliam Cho Original Research Article 06 June 2019 Pages: 873 - 887
Correction to: Safety, Tolerability, and Pharmacokinetics of GDC-0276, a Novel NaV1.7 Inhibitor, in a First-in-Human, Single- and Multiple-Dose Study in Healthy Volunteers Michael E. RothenbergMichael TagenWilliam Cho Correction 23 July 2019 Pages: 889 - 890
Determinants of Antithrombotic Treatment for Atrial Fibrillation in Octogenarians: Results of the OCTOFA Study Jacques BlacherEmmanuel SorbetsOlivier Hoffman Original Research Article 10 June 2019 Pages: 891 - 898
Hypertension and Health-Related Quality of Life (HRQoL): Evidence from the US Hispanic Population Elizabeth RileyJongwha ChangInho Song Original Research Article 12 June 2019 Pages: 899 - 908
Severe Exacerbation of Multiple Sclerosis Following Withdrawal of Fingolimod Yara D. FragosoTarso AdoniHeloisa H. Ruocco Short Communication 31 May 2019 Pages: 909 - 913
Correction to: Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features Katherine A. Lyseng-Williamson Correction 17 August 2019 Pages: 915 - 916